Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Peptides & Research Compounds
1
Posts
1
Users
0
Reactions
237
Views
Topic starter
14/08/2020 7:38 am
Trying to separate three different claims about LL-37: that it is the right molecule, that it is the right dose, and that it does something useful.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Injection site reactions are trivial until they are not, and a fresh needling technique removes half of them.
Where does the human data stop and the extrapolation start?